Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | University of Warwick |
| Country | United Kingdom |
| Start Date | Sep 29, 2024 |
| End Date | Sep 29, 2028 |
| Duration | 1,461 days |
| Number of Grantees | 1 |
| Roles | Supervisor |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2925294 |
Sleeping sickness, caused by the parasite Trypanosoma brucei, is a debilitating disease that affects many people in Africa. Current treatments are insufficient, and researchers are exploring new approaches to combat this condition. One such approach involves the use of tiny, specialized machines called nanosyringes, which can be produced by bacteria.
These nanosyringes are designed to inject toxins into cells, and scientists aim to engineer them to specifically target the parasites causing Sleeping sickness. The main goals of this research are to investigate whether these engineered nanosyringes can effectively bind to and kill the parasites, as well as to identify new molecules that can
be used to develop additional nanosyringe-based treatments. The researchers will test the effectiveness of these nanosyringes in a mouse model. Ultimately, this study aims to develop a versatile method for creating nanosyringes that could potentially be used to treat a variety of infectious diseases
University of Warwick
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant